[Changes in the electrophoretic picture of lipoproteins and glycoprotein fractions in arterial and venous blood of patients of arterial diseases after drug cocktail therapy].
D001798:Blood Proteins; D004586:Electrophoresis; D004876:Ergot Alkaloids / Q000627:therapeutic use*; D006634:Histamine H1 Antagonists / Q000627:therapeutic use*; D008074:Lipoproteins; D009525:Niacin / Q000627:therapeutic use*; D010208:Papaverine / Q000627:therapeutic use*; D016491:Peripheral Vascular Diseases / Q000628:therapy*; D014652:Vascular Diseases
D001798:Blood Proteins; D004876:Ergot Alkaloids; D006634:Histamine H1 Antagonists; D008074:Lipoproteins; D009525:Niacin; D010208:Papaverine
ANTIHISTAMINICS/therapeutic use; BLOOD PROTEINS; ERGOT ALKALOIDS/therapeutic use; NICOTINIC ACID/therapeutic use; PAPAVERINE/therapeutic use; VASCULAR DISEASES, PERIPHERAL/therapy
Modificazioni del quadro elettroforetico delle lipo-glico-sieroproteine arteriose e venose distrettuali in soggetti arteriopatici dopo trattamento con cocktail farmacologico.